Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells (Q42452556)

31 October 2017

Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells (English)

1 reference

31 October 2017

0 references

7

1 reference

31 October 2017

4

Alicja Józkowicz

1 reference

31 October 2017

2

Jozef Dulak

1 reference

31 October 2017

6

Hannes Alber

1 reference

31 October 2017

3

Jarosław Cisowski

1 reference

PubMed ID

14612202

31 October 2017

Severin P Schwarzacher

series ordinal

8

object named as

Severin P Schwarzacher

1 reference

31 October 2017

5

Ralf Zwick

1 reference

31 October 2017

9

Otmar Pachinger

1 reference

31 October 2017

Matthias Frick

1

1 reference

PubMed ID

14612202

31 October 2017

Franz Weidinger

series ordinal

10

1 reference

31 October 2017

1 October 2003

1 reference

31 October 2017

1 reference

31 October 2017

170

1 reference

31 October 2017

2

1 reference

31 October 2017

229-236

1 reference

Current perspectives on statins

31 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Statins do more than just lower cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Direct vascular effects of HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Molecular mechanisms of blood vessel growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Vascular endothelial growth factor: angiogenesis, atherogenesis or both?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on nitric oxide generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Statins have biphasic effects on angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Double-edged role of statins in angiogenesis signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Vascular endothelial growth factor enhances atherosclerotic plaque progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Role of Akt signaling in vascular homeostasis and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2803%2900299-5

10.1016/S0021-9150(03)00299-5

7 January 2021

Identifiers

DOI

1 reference

31 October 2017

1 reference

PubMed ID

14612202